Table of Content



1 Relevant Concepts of Capecitabine
1.1 Indications for Capecitabine
1.2 Development history of Capecitabine in China
1.3 Approval Information of Capecitabine in China
1.4 The Impact of COVID-19 on Capecitabine sales in China


2 Sales of Capecitabine in China, 2016-2020
2.1 Sales Value of Capecitabine
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Capecitabine
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Capecitabine by Dosage Form in China, 2016-2020
2.3.1 Tablets
2.3.2 Analysis of Other Dosage Forms


3 Analysis of Major Capecitabine Manufacturers in China, 2016-2020
3.1 Market Share Analysis of Major Capecitabine Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Shanghai Roche Pharmaceuticals Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China
3.3 Jiangsu Heng Rui Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Aibin (Jiangsu Hengrui Medicine Co,.Ltd.’s Capecitabine) in China
3.4 Qilu Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Zuolun (Qilu Pharmaceutical Co., Ltd. ’s Capecitabine) in China
3.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Shoufu (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.’s Capecitabine) in China
3.6 Hoffmann-La Roche Inc
3.6.1 Enterprise Profile
3.6.2 Sales of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China


4 Prices of Capecitabine of Different Manufacturers in China, 2020-2021
4.1 Shanghai Roche Pharmaceuticals Co., Ltd. (XELODA)
4.2 Jiangsu Hengrui Medicine Co,.Ltd. (Aibin)
4.3 Qilu Pharmaceutical Co., Ltd. (Zuolun)
4.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Shoufu)
4.5 Hoffmann-La Roche Inc (XELODA)


5 Prospect of Chinese Capecitabine drug Market, 2021-2025
5.1 Influential Factors of Chinese Capecitabine Market Development
5.1.1 The Impact of COVID-19 on Chinese Capecitabine Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Capecitabine Tablets Registration in China
Chart Sales Value of Capecitabine Tablets over the World
Chart Sales Value of Capecitabine Tablets in China, 2016-2020
Chart Sales Value of Capecitabine Tablets in China by Region, 2016-2020
Chart Sales Volume of Capecitabine Tablets in China, 2016-2020
Chart Sales Volume of Capecitabine Tablets in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Capecitabine Manufacturers in China, 2016-2020
Chart Sales Value and Volume of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China, 2016-2020
Chart Sales Value and Volume of Aibin in China, 2016-2020
Chart Sales Value and Volume of Zuolun in China, 2016-2020
Chart Sales Value and Volume of Shoufu in China, 2016-2020
Chart Sales Value and Volume of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China, 2016-2020
Chart Referential Prices of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China, 2020-2021
Chart Referential Prices of Aibin in China, 2020-2021
Chart Referential Prices of Zuolun in China, 2020-2021
Chart Referential Prices of Shoufu in China, 2020-2021
Chart Referential Prices of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China, 2020-2021
Chart Forecast on Sales Value of Capecitabine in China, 2021-2025
Chart Forecast on Sales Volume of Capecitabine in China, 2021-2025



List of Tables

Table of Contents


1 Relevant Concepts of Capecitabine   



  • 1.1 Indications for Capecitabine   

  • 1.2 Development history of Capecitabine in China     

  • 1.3 Approval Information of Capecitabine in China

  • 1.4 The Impact of COVID-19 on Capecitabine sales in China


 


2 Sales of Capecitabine in China, 2016-2020



  • 2.1 Sales Value of Capecitabine   

  • 2.1.1 Overall Sales Value

  • 2.1.2 Sales Value by Region 

  • 2.2 Sales Volume of Capecitabine

  • 2.2.1 Overall Sales Volume  

  • 2.2.2 Sales Volume by Region     

  • 2.3 Sales of Capecitabine by Dosage Form in China, 2016-2020

  • 2.3.1 Tablets

  • 2.3.2 Analysis of Other Dosage Forms


      


3 Analysis of Major Capecitabine Manufacturers in China, 2016-2020     



  • 3.1 Market Share Analysis of Major Capecitabine Manufacturers

  • 3.1.1 Market Share by Sales Value

  • 3.1.2 Market Share by Sales Volume   

  • 3.2 Shanghai Roche Pharmaceuticals Co., Ltd.   

  • 3.2.1 Enterprise Profile 

  • 3.2.2 Sales of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China

  • 3.3  Jiangsu Heng Rui Pharmaceutical Co., Ltd.

  • 3.3.1 Enterprise Profile 

  • 3.3.2 Sales of Aibin (Jiangsu Hengrui Medicine Co,.Ltd.’s Capecitabine) in China

  • 3.4 Qilu Pharmaceutical Co., Ltd.

  • 3.4.1 Enterprise Profile 

  • 3.4.2 Sales of Zuolun (Qilu Pharmaceutical Co., Ltd. ’s Capecitabine) in China

  • 3.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  • 3.5.1 Enterprise Profile 

  • 3.5.2 Sales of Shoufu (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.’s Capecitabine) in China

  • 3.6 Hoffmann-La Roche Inc

  • 3.6.1 Enterprise Profile 

  • 3.6.2 Sales of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China


 


4 Prices of Capecitabine of Different Manufacturers in China, 2020-2021



  • 4.1 Shanghai Roche Pharmaceuticals Co., Ltd. (XELODA)

  • 4.2 Jiangsu Hengrui Medicine Co,.Ltd. (Aibin)

  • 4.3 Qilu Pharmaceutical Co., Ltd. (Zuolun)

  • 4.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Shoufu)

  • 4.5 Hoffmann-La Roche Inc (XELODA)


 


5 Prospect of Chinese Capecitabine drug Market, 2021-2025



  • 5.1 Influential Factors of Chinese Capecitabine Market Development

  • 5.1.1 The Impact of COVID-19 on Chinese Capecitabine Market

  • 5.1.2 Market Drivers and Opportunities

  • 5.1.3 Market Threats and Challenges

  • 5.2 Forecast on Market Size 

  • 5.3 Forecast on Market Trend

  •  


List of Charts



  • Chart Patent Information About Capecitabine Tablets Registration in China

  • Chart Sales Value of Capecitabine Tablets over the World  

  • Chart Sales Value of Capecitabine Tablets in China, 2016-2020 

  • Chart Sales Value of Capecitabine Tablets in China by Region, 2016-2020

  • Chart Sales Volume of Capecitabine Tablets in China, 2016-2020     

  • Chart Sales Volume of Capecitabine Tablets in China by Region, 2016-2020

  • Chart Market Share by Sales Value of Top Capecitabine Manufacturers in China, 2016-2020

  • Chart Sales Value and Volume of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China, 2016-2020     

  • Chart Sales Value and Volume of Aibin in China, 2016-2020

  • Chart Sales Value and Volume of Zuolun in China, 2016-2020  

  • Chart Sales Value and Volume of Shoufu in China, 2016-2020   

  • Chart Sales Value and Volume of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China, 2016-2020           

  • Chart Referential Prices of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China, 2020-2021     

  • Chart Referential Prices of Aibin in China, 2020-2021        

  • Chart Referential Prices of Zuolun in China, 2020-2021           

  • Chart Referential Prices of Shoufu in China, 2020-2021     

  • Chart Referential Prices of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China, 2020-2021

  • Chart Forecast on Sales Value of Capecitabine in China, 2021-2025

  • Chart Forecast on Sales Volume of Capecitabine in China, 2021-2025